Ownership history in ORBIMED ADVISORS LLC · 8 quarters on record
This page tracks every 13F SEC filing in which ORBIMED ADVISORS LLC reported a position in ARRIVENT BIOPHARMA INC (AVBP). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | UNCHANGED | 3,027,328 | — | 0% | 1.24% | $60.9M | $20.12 |
| 2025 Q3 | UNCHANGED | 3,027,328 | — | 0% | 1.31% | $55.9M | $18.45 |
| 2025 Q2 | UNCHANGED | 3,027,328 | — | 0% | 1.65% | $65.9M | $21.77 |
| 2025 Q1 | UNCHANGED | 3,027,328 | — | 0% | 1.33% | $56.0M | $18.49 |
| 2024 Q4 | UNCHANGED | 3,027,328 | — | 0% | 1.66% | $80.6M | $26.64 |
| 2024 Q3 | UNCHANGED | 3,027,328 | — | 0% | 1.29% | $71.1M | $23.50 |
| 2024 Q2 | UNCHANGED | 3,027,328 | — | 0% | 1.11% | $56.2M | $18.55 |
| 2024 Q1 | INITIATED | 3,027,328 | — | — | 0.99% | $54.1M | — |
As of 2025 Q4 — sorted by position size